Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Edoxaban versus warfarin in patients with atrial fibrillation.
- R. Giugliano, C. Ruff, +18 authors E. Antman
- The New England journal of medicine
- 27 November 2013
Both once-daily regimens of edoxaban were noninferior to warfarin with respect to the prevention of stroke or systemic embolism and were associated with significantly lower rates of bleeding and death from cardiovascular causes. Expand
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
In patients with a prior myocardial infarction who are at high risk for ventricular tachyarrhythmia, prophylactic therapy with an implanted defibrillator leads to improved survival as compared with conventional medical therapy. Expand
A comparison of rate control and rhythm control in patients with atrial fibrillation.
Management of atrial fibrillation with the rhythm-control strategy offers no survival advantage over the rate- control strategy, and there are potential advantages, such as a lower risk of adverse drug effects, with the rate -control strategy. Expand
Subclinical atrial fibrillation and the risk of stroke.
Pathophysiology and Prevention of Atrial Fibrillation
Atrial fibrillation (AF) is a ubiquitous yet diverse cardiac arrhythmia whose incidence increases with age; with most forms of cardiac and some pulmonary diseases; and with a number of metabolic,… Expand
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
An “on-treatment” analysis of the relationship of survival to cardiac rhythm and treatment as they changed over time suggests that any beneficial antiarrhythmic effects of AADs are offset by their adverse effects. Expand
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
The prophylactic use of a specific potassium-channel blocker does not reduce mortality, and may be associated with increased mortality in high-risk patients after myocardial infarction. Expand
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
- A. Waldo
Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop
The panel proposed the following recommendations to enhance understanding of the epidemiology of AF in the population by systematically and longitudinally investigating symptomatic and asymptomatic AF in cohort studies. Expand
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.
- G. Frendl, Alissa C Sodickson, +13 authors D. Adler
- The Journal of thoracic and cardiovascular…
- 1 September 2014
PREAMBLE Our mission was to develop evidence-based guidelines for the prevention and treatment of perioperative/postoperative atrial fibrillation and flutter (POAF) for thoracic surgical procedures.… Expand